Opiant Pharmaceuticals, Inc.
(NASDAQ : OPNT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
0.33%183.581.1%$862.96m
GILDGilead Sciences, Inc.
-0.31%80.690.9%$827.70m
CELGCelgene Corporation
0.94%94.731.2%$768.02m
JUNOJuno Therapeutics, Inc.
1.95%86.6413.5%$580.17m
BIIBBiogen Inc.
0.32%288.381.2%$511.59m
REGNRegeneron Pharmaceuticals, Inc.
-1.15%319.342.7%$396.15m
VRTXVertex Pharmaceuticals Incorporated
-1.55%158.491.9%$353.80m
ALXNAlexion Pharmaceuticals, Inc.
-0.53%118.222.0%$255.26m
NKTRNektar Therapeutics
1.21%84.466.0%$250.04m
ILMNIllumina, Inc.
0.01%226.583.5%$230.72m
BLUEBluebird Bio, Inc.
2.31%210.1916.1%$196.38m
AAgilent Technologies, Inc.
1.44%72.101.5%$178.13m
INCYIncyte Corporation
0.48%85.922.5%$154.85m
BMRNBioMarin Pharmaceutical Inc.
1.05%84.734.4%$122.45m
EXASExact Sciences Corporation
-0.35%47.8426.0%$117.75m

Company Profile

Opiant Pharmaceuticals, Inc. is a biopharmaceutical company, which develops pharmaceutical solutions for common addictions and related disorders. The company focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Santa Monica, CA.